Abstract
Cancer cell-specific synthetic lethal interactions entail promising therapeutic possibilities. In this issue of Cancer Cell, Pfister et al. describe a synthetic lethal interaction where cancer cells deficient in H3K36me3 owing to SETD2 loss-of-function mutation are strongly sensitized to inhibition of WEE1, a cell cycle controlling kinase.
Original language | English |
---|---|
Journal | Cancer Cell |
Volume | 28 |
Issue number | 5 |
Pages (from-to) | 545-547 |
Number of pages | 3 |
ISSN | 1535-6108 |
DOIs | |
Publication status | Published - 9 Nov 2015 |
Keywords
- Animals
- Cell Cycle Proteins
- Histones
- Humans
- Neoplasms
- Nuclear Proteins
- Nucleotides
- Protein-Tyrosine Kinases
- Comment
- Journal Article